Sanjay Verma of Akums Drugs & Pharmaceuticals, Manu Gupta of Cadila Pharmaceuticals, Rahul Borse of RPG Life Sciences, Krishna Sai T of Biocon and Amit Saluja of NASSCOM are speakers
Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors
.jpeg)
One of our major priorities in next 3-5 years is the introduction of a kit-based version of CanAssist Breast, enabling hospitals conduct the test locally
Leading experts from AIIMS Kalyani, Syngene, Veeda Lifesciences, Lambda Therapeutic, DNDi, JSS Medical, KIHT, InoRx, ISCR and SIRO Clintech to discuss India’s readiness as preferred clinical research destination
Since 2022, we have grown threefold and our growth story is built on scale, scientific innovation and deep customer partnerships
We are building the bridge between complex molecular data and everyday clinical decisions
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
The event is expected to attract more than 100 senior professionals from pharmaceutical companies, CROs, regulatory agencies, and technology organisations
Access to genomic testing, not therapy cost, is the biggest challenge
We are building an AI-native operating system for pharma sales and distribution
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
